He, Yibo
Ge, Changrong
Moreno-Giró, Àlex http://orcid.org/0000-0002-4655-1639
Xu, Bingze
Beusch, Christian M. http://orcid.org/0000-0001-9100-8283
Sandor, Katalin http://orcid.org/0000-0003-3228-6907
Su, Jie http://orcid.org/0000-0001-9828-9794
Cheng, Lei
Lönnblom, Erik http://orcid.org/0000-0002-1311-2541
Lundqvist, Christina http://orcid.org/0000-0002-2256-4072
Slot, Linda M.
Tong, Dongmei
Urbonaviciute, Vilma
Liang, Bibo
Li, Taotao
Lahore, Gonzalo Fernandez
Aoun, Mike
Malmström, Vivianne http://orcid.org/0000-0001-9251-8082
Rispens, Theo http://orcid.org/0000-0001-9600-1312
Ernfors, Patrik http://orcid.org/0000-0002-1140-3986
Svensson, Camilla I.
Scherer, Hans Ulrich http://orcid.org/0000-0002-5700-5617
Toes, René E. M. http://orcid.org/0000-0002-9618-6414
Gjertsson, Inger
Ekwall, Olov http://orcid.org/0000-0002-4506-9955
Zubarev, Roman A. http://orcid.org/0000-0001-9839-2089
Holmdahl, Rikard http://orcid.org/0000-0002-4969-2576
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (2019-0059)
National Natural Science Foundation of China (32070913)
Vetenskapsrådet (2019-01209)
Article History
Received: 12 September 2022
Accepted: 20 January 2023
First Online: 8 February 2023
Competing interests
: C.G., B.X., T.R., and R.H. are the co-inventors of a patent application (PCT/EP2018/082236) related to ACPA specificity and their use in the diagnosis, prevention, and treatment of autoimmune diseases. H.U.S. and R.E.M.T. are mentioned as inventors on a patent on ACPA-IgG V-domain glycosylation. The remaining authors declare no competing interests.